These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15177414)

  • 1. Linear deposition of immunoglobulins and complement components on the dura in normal pressure hydrocephalus complicating systemic lupus erythematosus.
    Honda K; Matsumoto M; Kaneko T; Kamei I; Tatsumi H; Murai N; Mineharu Y; Oita J
    J Clin Neurosci; 2004 Jun; 11(5):561-3. PubMed ID: 15177414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal pressure hydrocephalus in a patient with systemic lupus erythematosus.
    Uhl MD; Werner BE; Romano TJ; Zidar BL
    J Rheumatol; 1990 Dec; 17(12):1689-91. PubMed ID: 2084247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child.
    Yamazaki-Nakashimada MA; Duran-McKinster C; Ramírez-Vargas N; Hernandez-Bautista V
    Pediatr Dermatol; 2009; 26(4):445-7. PubMed ID: 19689522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody-mediated neuroinflammation: pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model.
    Mondal TK; Saha SK; Miller VM; Seegal RF; Lawrence DA
    Brain Behav Immun; 2008 Aug; 22(6):949-59. PubMed ID: 18411022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.
    Cook HT; Botto M
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):330-7. PubMed ID: 16932712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric manifestations in systemic lupus erythematosus.
    Stojanovich L; Zandman-Goddard G; Pavlovich S; Sikanich N
    Autoimmun Rev; 2007 Jun; 6(6):421-6. PubMed ID: 17537389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurological disorders in systemic lupus erythematosus patients].
    Hawro T; Bogucki A; Sysa-Jedrzejowska A; Bogaczewicz J; Woźniacka A
    Pol Merkur Lekarski; 2009 Jan; 26(151):43-8. PubMed ID: 19391506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome.
    Mehta LR; Samuelsson MK; Kleiner AK; Goodman AD; Anolik JH; Looney RJ; Schwid SR
    Mult Scler; 2008 Apr; 14(3):425-7. PubMed ID: 18208886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of vasculitis of the central nervous system in a patient with systemic lupus erythematosus.
    Nikolov NP; Smith JA; Patronas NJ; Illei GG
    Nat Clin Pract Rheumatol; 2006 Nov; 2(11):627-33; quiz 634. PubMed ID: 17075602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct immunofluorescence in granuloma faciale: a case report and review of literature.
    Barnadas MA; Curell R; Alomar A
    J Cutan Pathol; 2006 Jul; 33(7):508-11. PubMed ID: 16872475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal pressure hydrocephalus in the spectrum of neurological complications of systemic lupus erythematosus.
    de Oliveira FF; Cardoso TA; Sampaio-Barros PD; Damasceno BP
    Neurol Sci; 2013 Jun; 34(6):1009-13. PubMed ID: 22829132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus.
    Yoshio T; Onda K; Nara H; Minota S
    Arthritis Rheum; 2006 Feb; 54(2):675-8. PubMed ID: 16447246
    [No Abstract]   [Full Text] [Related]  

  • 14. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of anti-glial fibrillary acidic protein antibodies in the pathogenesis of neuropsychiatric systemic lupus erythematosus should be clarified: comment on the article by Trysberg et al.
    Alessandri C; Conti F; Valesini G
    Arthritis Rheum; 2004 May; 50(5):1698-9; author reply 1699. PubMed ID: 15146449
    [No Abstract]   [Full Text] [Related]  

  • 16. [Initial manifestation by cerebral vasculitis in systemic lupus erythematosus].
    Mrabet D; Meddeb N; Sahli H; Rammeh N; Sellami S
    Tunis Med; 2008 Jun; 86(6):618-9. PubMed ID: 19216467
    [No Abstract]   [Full Text] [Related]  

  • 17. Premature atherosclerosis-related central nervous system involvement in two cases of systemic lupus erythematosus.
    Zhang X; Tian X; Zhang F
    J Clin Rheumatol; 2007 Aug; 13(4):211-2. PubMed ID: 17762456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus.
    Lampropoulos CE; Koutroumanidis M; Reynolds PP; Manidakis I; Hughes GR; D'Cruz DP
    Arthritis Rheum; 2005 Mar; 52(3):841-6. PubMed ID: 15751063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous systemic lupus erythematosus responding to dapsone.
    Ludgate MW; Greig DE
    Australas J Dermatol; 2008 May; 49(2):91-3. PubMed ID: 18412808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease?
    Senécal JL; Raymond Y
    J Rheumatol; 2004 Nov; 31(11):2093-8. PubMed ID: 15517616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.